Dyskeratosis congenita associated with immune defects [15 genes]

Dyskeratosis congenita (DC) is a complex syndrome characterized by immunodeficiency, bone marrow failure, somatic abnormalities, and predisposition to cancer.

T lymphocyte dysfunction is caused by a defect in telomerase complexes, whose function is to protect telomeres from degradation. When telomerase complexes do not function correctly, telomeres are unprotected and their degradation speeds up. DC is caused by alterations in the genes that encode the proteins that compose the telomerase and shelterin complexes.

  • 1/100.000 – 1/1.000.000 individuals

  • Diagnosis and genetic counseling
  • Anabolic steroids
  • Granulocyte colony-stimulating factors
  • Hematopoietic stem cell transplantation (HSCT)

  • Recurring infections
  • Ungual dystrophy
  • Leukoplakia
  • Skin pigmentation, white hair
  • Hypogammaglobulinemia
  • Increased risk of cancer
  • Onset: neonatal, infancy, childhood, adolescence

Request study Informed consent
Steps to follow
Steps to follow
Click here to see the Guidelines for the collection and transport of biological samples

1) Download & fill out

Please cover as many fields as possible in both documents

2) Sample collection

See sample types in the guidelines

3) Pack the sample

Please pack the sample in a way to prevent leakage

4) Send the sample & the request

Please schedule the delivery for Monday–Friday: 8am – 5pm

5) Result: the report

Via: e-mail and/or through the customer portal

Ask for information
Solicita información de

Dyskeratosis congenita associated with immune defects

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Consentimiento*
Technique: NGS capture panel

Turnaround time (TAT): 25 days

Ref. S-202008261

Updated (dd/mm/yy): 13/03/2025

Dyskeratosis congenita associated with immune defects: View panel
  • ACD
  • CTC1
  • DCLRE1B
  • DKC1
  • NHP2
  • NOP10
  • PARN
  • RTEL1
  • SAMD9
  • SAMD9L
  • STN1
  • TERT
  • TINF2
  • USB1
  • WRAP53

Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.

References

  1. Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol. 2013;6(3):327-337. doi:10.1586/ehm.13.23
  2. Bar, C., Povedano, J. M., Serrano, R., Benitez-Buelga, C., Popkes, M., Formentini, I., … Blasco, M. A. (2016). Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia. Blood, 127(14), 1770–1779. https://doi.org/10.1182/blood-2015-08-667485
  3. Baran I, Nalcaci R, Kocak M. Dyskeratosis congenita: clinical report and review of the literature. Int J Dent Hyg. 2010;8(1):68-74. doi:10.1111/j.1601-5037.2009.00364.x
  4. Jyonouchi S, Forbes L, Ruchelli E, Sullivan KE. Dyskeratosis congenita: A combined immunodeficiency with broad clinical spectrum – a single-center pediatric experience. Pediatr Allergy Immunol. 2011;22(3):313-319. doi:10.1111/j.1399-3038.2010.01136.x
  5. Walne AJ, Bhagat T, Kirwan M, et al. Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica. 2013;98(3):334-338. doi:10.3324/haematol.2012.071068

Basic information about cookies

Welcome to the basic information about cookies on the website under the responsibility of the entity:

HEALTH IN CODE SL

A cookie is a small information file that is stored in your computer, smartphone or tablet every time you visit our website. Some cookies are ours (we will call them our own cookies) and others belong to external companies that provide services for our website.

Cookies can be of various types: technical cookies are necessary for our website to function; they do not require your permission and are the only ones we have enabled by default.

The other cookies are used to improve our website, to personalise it based on your preferences, or to be able to show you advertising tailored to your searches, preferences, and personal interests. You can accept all these cookies by clicking on the ACCEPT button or REFUSE button below.

For more information, please consult the COOKIES POLICY on our website.